Showing results (171-180 of 214) with videos related to
Sort By:
Pageof 22
Frontiers in Immunology|July 26, 2021
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesElena E Perez, Jacques Hébert, Anne K Ellis, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 9, 2022
Information needs of patients considering oral immunotherapy for food allergyDouglas Paul Mack, Matthew Greenhawt, Paul J Turner, et al.Clinical and Experimental Immunology|July 11, 2012
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapyJ S Orange, B H Belohradsky, M Berger, et al.Journal of Clinical Immunology|August 19, 2024
Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety StudyArye Rubinstein, Mohsen Mabudian, Donald McNeil, et al.Pediatrics|February 1, 1990
Lack of transmission of human immunodeficiency virus from infected children to their household contactsM F Rogers, C R White, R Sanders, et al.International Journal of Medical Informatics|January 23, 2025
Development of a drug allergy alert tiering algorithm for penicillins and cephalosporinsRachel L Wasserman, Heba H Edrees, Diane L Seger, et al.Journal of Clinical Immunology|June 22, 2016
Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency DiseaseRichard L Wasserman, William Lumry, James Harris, et al.Journal of Clinical Immunology|July 17, 2010
Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedemaTimothy J Craig, Richard L Wasserman, Robyn J Levy, et al.Immunotherapy|September 21, 2022
Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pumpRichard L Wasserman, Charlotte Cunningham-Rundles, John Anderson, et al.The Journal of Allergy and Clinical Immunology|August 1, 2012
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiencyRichard L Wasserman, Isaac Melamed, Mark R Stein, et al.Pageof 22